Advertisement
CRISPR Therapeutics Says FDA Grants RMAT Designation To CTX130
(RTTNews) - Biopharmaceutical company CRISPR Therapeutics (CRSP) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX130, the Company's wholly-owned allogeneic CAR T cell therapy targeting CD70, for the treatment of Mycosis Fungoides and Sézary Syndrome (MF/SS).
Established under the 21st Century Cures Act, RMAT designation is a dedicated program designed to expedite the drug development and review processes for promising pipeline products, including genetic therapies.
Similar to Breakthrough Therapy designation, RMAT designation provides the benefits of intensive FDA guidance on efficient drug development.
For More Such Health News, visit rttnews.com
read more
Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology
Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).
RTTNews
|
874 days ago
Yen Falls Amid Risk-on Mood
The Japanese yen weakened against other major currencies in the Asian session on Monday as Asian stock markets traded higher, amid expectations of the three-year-plus war between Russia and Ukraine ending soon, with U.S. President Donald Trump saying he and Russian President Putin discussed land transfers and security guarantees for Ukraine and had "largely agreed".
RTTNews
|
1h 55min ago
Yen Falls Against Majors
The Japanese yen weakened against other major currencies in the Asian session on Monday.
RTTNews
|
2h 6min ago
European Shares Seen Opening Up On Russia-Ukraine Hopes
European stocks are seen opening a tad higher on Monday as hope prevails for a swift resolution to the Russia-Ukraine conflict.
RTTNews
|
2h 15min ago
Sensex, Nifty Rally As Automakers Surge On Modi's Big GST Reform Push
Indian shares opened on a buoyant note on Monday after S&P Global Ratings upgraded India's sovereign ratings and Prime Minister Narendra Modi promised next generational GST reforms by Diwali, which will bring down the tax burden on consumers as well as MSMEs.
RTTNews
|
3h 27min ago
Australian Market Trims Early Losses In Mid-market
The Australian stock market is trimming its early losses in choppy mid-market trading on Monday, after opening in the red and briefly treading in to the green, reversing some of the gains in the previous two sessions, following the mixed cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is staying above the 8,900.00 level, with weakness in mining and energy stocks.
RTTNews
|
4h 20min ago
Asian Markets Trade Mostly Higher
Asian stock markets are trading mostly higher on Monday, following the mixed cues from Wall Street on Friday, amid expectations of the three-year-plus war between Russia and Ukraine ending soon, with U.S. President Donald Trump saying he and Russian President Putin discussed land transfers and security guarantees for Ukraine, and had "largely agreed". Asian markets closed mostly higher on Friday.
RTTNews
|
4h 42min ago
Sensex, Nifty Seen Higher On Proposed GST Reforms Push
Indian shares look set to open on a positive note Monday after S&P Global Ratings upgraded India's sovereign ratings, citing buoyant economic growth, enhanced monetary policy conditions and the government's fiscal consolidation commitment.
RTTNews
|
5h 16min ago
